私募大佬胡建平，重磅发声！

Core Viewpoint - The global economic landscape is undergoing profound changes, yet market pricing has not fully reflected these shifts. The construction of a unified market is expected to enhance industrial quality and efficiency, with opportunities in overseas expansion, the pharmaceutical industry, and AI technology being highlighted as key investment themes for the future [2][4][12]. Investment Insights - In reviewing investment operations for 2025, the company noted gains in sectors such as biopharmaceuticals, new consumption, AI applications, and precious metals, while acknowledging missed opportunities in the AI supply chain affecting industries like electricity and PCB [5]. - The company emphasizes the importance of value investing and the integration of AI tools to enhance investment decision-making, aiming to combine professional judgment with technological capabilities [5][3]. Market Dynamics - The company observes that the capital market's response to changes in the global economic structure has been slow, with many assets, particularly in China, remaining undervalued. The rising prices of gold and certain mineral resources are seen as initial indicators of this shift [5][6]. - The Chinese capital market has experienced significant changes, with a notable recovery from previous bubbles and a shift towards a more robust economic structure, particularly in green industrial revolutions and sectors like biopharmaceuticals and semiconductors [6][10]. Opportunities in Overseas Expansion - The company identifies overseas expansion as a long-term investment theme, highlighting the advantages of China's high-quality human resources across various fields, which positions it well for global investments [11]. - The focus on overseas opportunities includes sectors such as computing supply chains and biopharmaceuticals, reflecting a shift from traditional investment strategies to a more global perspective [11]. Pharmaceutical Industry Outlook - The pharmaceutical sector is viewed as entering a new growth phase, with significant potential for innovation and international collaboration. The industry is transitioning from generic drug manufacturing to research and development, with a strong emphasis on clinical standards and innovative drug policies [13]. - The competitive landscape in pharmaceuticals is expected to intensify, with a focus on high-stakes innovation and the potential for significant market shifts as companies navigate the clinical development process [13]. Consumer Sector Trends - The consumer sector is experiencing a transformation, with traditional consumption patterns evolving. Opportunities are emerging in service-oriented consumption and innovative supply chain efficiencies, driven by new consumer demands [14]. - The company notes that AI remains a critical area for investment, with the potential for significant disruptions in various industries as AI applications continue to develop [14].